Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Angiogenic factors and preeclampsiaMay Lee Tjoa, Richard J Levine, S Ananth Karumanchi
BMC Pregnancy and Childbirth|January 7, 2023
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscapeDerek P de Winter, Allysen Kaminski, May Lee Tjoa, et al.
BMC Pregnancy and Childbirth|October 18, 2023
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomesDerek P de Winter, Allysen Kaminski, May Lee Tjoa, et al.
AJOG Global Reports|May 25, 2023
Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010Devin Yu, Leona E Ling, Alexis A Krumme, et al.
The American Journal of Pathology|August 1, 2006
Trophoblastic oxidative stress and the release of cell-free feto-placental DNAMay Lee Tjoa, Tereza Cindrova-Davies, Olivera Spasic-Boskovic, et al.
Annals of the New York Academy of Sciences|November 17, 2006
Fetal nucleic acids in maternal body fluids: an updateDiana W Bianchi, Tuangsit Wataganara, Olav Lapaire, et al.
Hypertension in Pregnancy|September 17, 2004
Markers for presymptomatic prediction of preeclampsia and intrauterine growth restrictionMay Lee Tjoa, Cees B M Oudejans, John M G van Vugt, et al.
Diabetes Care|December 17, 2009
First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitusRavi Thadhani, Camille E Powe, May Lee Tjoa, et al.
AJOG Global Reports|March 4, 2025
Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunizationAlexis A Krumme, Robert Y Suruki, Clair Blacketer, et al.
American Journal of Perinatology|March 6, 2025
Plain Language Summary of Publication: Design of the Phase 3 AZALEA Trial of Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornYosuke Komatsu, Victor Olusajo, Leona E Ling, et al.
Pageof 3